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Available online 20 March 2008Calreticulin is a lectin chaperone essential for intracellular calcium homeostasis. Deletion of calreticulin gene
compromises the overall quality control within the endoplasmic reticulum (ER) leading to activation of the
unfolded protein response. However, the ER structure of calreticulin deﬁcient cells (crt−/−) is not altered due
to accumulation of misfolded proteins. Therefore, the aim of this study was to determine whether the
ubiquitin–proteasome pathway is activated in crt−/− cells as a compensatory mechanism for cell survival.
Here we show a signiﬁcant increase in the expression of genes involved in ER associated degradation and
activation of the ubiquitin–proteasome system in crt−/− cells. We also demonstrated that the ubiquitination of
two proteins processed in ER, connexin 43 and A1AT NHK (α1-antitrypsin mutant) are increased in crt−/−
cells. Furthermore, we showed that the increased proteasome activity in the crt−/− cells could be rescued
upon re-introduction of calreticulin or calsequestrin (a muscle calcium binding protein). We also illustrated
that increased cytosolic Ca2+ enhances the proteasome activity. Interestingly, suppression of calnexin function
using siRNA further elevated the proteasome activity in crt−/− cells. This is the ﬁrst report to show that loss of
calreticulin function enhances the ubiquitin–proteasome activity which could function as a compensatory
mechanism for cell survival.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Many cellular proteins are synthesized and folded in the
endoplasmic reticulum (ER). The biosynthesis of properly folded and
biologically active proteins in the ER is maintained by the “quality
control” process which involves a number of ER chaperones including
BiP/GRP78, calnexin and calreticulin [1]. Any disruption in the ER
quality control results in the accumulation of unfolded (or misfolded)
proteins in the ER and thereby activates the Unfolded Protein Re-
sponse (UPR). UPR induces the expression of ER chaperones in an
effort to increase the folding capacity of the ER and thus prevent
clogging of the ER by unfolded proteins [2,3]. Accumulation of mis-
folded proteins in the ER activates ER associated degradation (ERAD)
via the ubiquitin–proteasome pathway [4].
In the ER lumen, N-glycosylated proteins associate with calnexin/
calreticulin in order to promote correct disulﬁde bond formation and
facilitate their proper folding and maturation [5,6]. To prevent protein
aggregation, misfolded N-glycosylated proteins associate with the
calnexin/calreticulin chaperones for a longer duration which can leadSciences, St. Boniface General
, Manitoba, Canada R2H 2A6.
t; wt, wild type; ER, Endoplas-
nfolded protein response
l rights reserved.to the initiation of ERAD [7]. To exit the calnexin/calreticulin cycle and
to enter the ERAD, the glycoproteins require de-mannosylation by
α1,2-mannosidase I [8,9]. EDEM, an α-mannosidase like protein, in-
teracts directly with calnexin and extracts terminally misfolded pro-
teins from the calnexin/calreticulin cycle [10,11]. The N-glycans are
then exported to the cytosol via the translocon channel [12]. In yeast,
the Sec61/Der1 protein complex has been shown to form the ER
export channel [12]. Once in the cytosol, the misfolded proteins are
ubiquitiniated by Hrd1, a multi-spanning membrane protein with
RING-ﬁnger type domain, which targets misfolded proteins for de-
gradation by the 26S proteasome [13].
Calreticulin is a ubiquitous ER proteinwhich is subdivided into three
functional domains (reviewed in [14]). The N-domain (aa 1–180) is the
most conserved region of the protein among different species and is
important for interaction with other ER chaperones and zinc binding.
The P domain (proline rich regionof calreticulin, aa 181–280) is involved
in lectin-like chaperone activity and is essential for the high afﬁnity low
capacity Ca2+ binding. The C-domain of calreticulin is highly acidic and
binds Ca2+ with high capacity and low afﬁnity, thus plays a role in Ca2+
storage and homeostasis in the lumen of the ER. As an ER chaperone,
calreticulin is involved in the folding of glycoproteins and plays an
important role in the ER quality control process [15,16]. Gene targeted
deletion of calreticulin induces ER stress and activates UPR as evident by
a signiﬁcant increase in the level of BiP/GRP78, Ire1α and PERK [17].
However, no signiﬁcant protein aggregation in the ER or changes in the
ER structure (electronmicroscopic analysis, as seen inFig.1A) occurs due
Fig. 1. (A) Electronmigrograph ofwt and crt−/− cells showing no signiﬁcant change in the ultrastructure of the endoplasmic reticulum upon loss of CRT function (arrowheads). Images
were captured on Kodak electronmicroscope ﬁlm negatives at a magniﬁcation of 10,000×. (B) Increased level of ubiquitinated proteins in crt−/− cells following proteasome inhibition.
Ubiquitinated proteins were enriched using ubiquitin afﬁnity beads. Proteins were then resolved on 10% SDS page and followed by western blot with anti-ubiquitin antibody. Bar
graph is quantiﬁcation of total ubiquitinated proteins in the wt and crt−/− cells. The values are mean±SE of three separate experiments. * pb0.05 signiﬁcantly different as compared
to untreated cells, # pb0.05 as compared to wt cells treated with 50 μM MG132. (C) Ubiquitination of ectopically expressed mutant α1-antitrypsin (NHK) and endogenously
expressed Connexin 43 (Cx43) which are both processed in the ER were examined in crt−/− and wt cells. Ubiquitinated protein were enriched using ubiquitin afﬁnity beads. Right
panel shows western blot with anti-NHK antibody of ubiquitinated NHK (upper blot) and total non-ubiquitinated NHK (lower blot). Left panel shows the level of ubiquitinated Cx43
in crt−/− after ubiquitin pull down and subsequent treatment with isopeptidase (to release Cx43 from ubiquitin chains) and total levels of Cx43 detected in crt−/− cells. (D) Changes in
proteasome activity in crt−/− cells as compared to wt cells. Chymotrypsin like activity were measured by monitoring the release of free AMC (amidomethylcoumarin) from the
ﬂuorogenic peptide Suc-Leu-Leu-Val-Tyr-AMC (Ex.: 380 nm; Em.: 460 nm). The values are mean±SE of three separate experiments. (E) Substrate overlay assay to differentiate
between the activity of 20S and 26S proteasome. Lane 1 is commercially available puriﬁed 20S proteasome complex and lane 2 is cell lysates fromwt cells. (F) Changes in proteasome
activity in crt−/− cells as compared to wt cells. 100 μg of protein cell lysate from wt and crt−/− cells were prepared as above. The Suc-LLVY-AMC-hydrolysing activity of the samples
were detected by overlay technique. In Fig. 1E, F the loading wells are cut off. The extra bands on top of the gels, indicated by asterisk, are artifact of the junction between the stacking
and separating gels.
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demonstrated that in crt−/− cells many proteins are either malformed,
e.g. bradykinin receptor [18] and MHC class I [19], or their level is
signiﬁcantly decreased, e.g. p53 [20] and IP3 receptor [18]. The majority
of these proteins are known to be degraded via the ubiquitin–pro-
teasome pathway. Therefore the aim of this study was to investigate
changes inprotein ubiquitination and rate of protein degradation via the
proteasome pathway upon loss of calreticulin function.
2. Materials and methods
2.1. Cell culture and treatments
Mouse embryonic ﬁbroblasts (MEF) were isolated from 14 day old wild type (wt)
and calreticulin knockout (crt−/−) mouse embryos as described previously [20]. Cells
were grown in Dulbecco's Modiﬁed Eagle's Medium (DMEM) and 10% fetal bovine
serum (FBS, Invitrogen). For cell treatments, different inhibitors were dissolved in
DMSO or water. The ﬁnal concentration of DMSO in the media did not exceed 0.1% at
any time. In control cells, 0.1% DMSOwas added to the media. The inhibitors used were:
MG132 (proteasome inhibitor), lactacystin (proteasome inhibitor), thapsigargin
(inhibitor of ER Ca2+-ATPase), brefeldin A (disrupts Golgi, Calbiochem), tunicamycin
(inhibitor of N-linked glycosylation) and ionomycin (Ca2+ ionophore, Sigma).
2.2. Transient transfections
wt and crt−/− MEF were transiently transfected with 15 µg of plasmid DNA
(pCMV5A-BiP, pCMV5A-calnexin, pcDNA-hATNHK, pcDNA-CRT-HA, pcDNA-CRTNP,
pcDNA-CRTPC, pcDNA-CRTW244A pcDNA-CRTNP W244A, pcDNA-CRTPC W244A pSVL-
Calsequestrin or their respective empty vector) using Lipofectamine2000 (Invitrogen).
The next day, the media was replaced with DMEM containing 10% FBS. 48 h after
transfection the cells were used for Western blot or proteasome assay. Site-speciﬁcmutagenesis of the Trp244 residue (disrupts P-domain folding) of calreticulin and
deletion mutants was performed using an overlap extension polymerase chain reaction
technique [21]. The PCR reactionwas carried out using PfxDNA polymerase and primers
listed in Table 1.
2.3. siRNA transfection
2.5×105 cells were plated in 6 well plates. Next day, the media was replaced with
Opti-MEMmedia (Invitrogen) and cellswere transfectedwith 80 pmol of calnexin siRNA
or a control siRNA (siRNA-A, Santa Cruz Biotechnology) using Lipofectamine2000. Six
hours after transfection, the media was changed to DMEM supplemented with 2% FBS
and cells were incubated for 24 h. Cells were then used for proteasome activity and
Western blot analysis.
2.4. Ubiquitin pull down assay
Total cellular ubiquitinated proteins were pulled down using an ubiquitin
enrichment kit (Calbiochem) following the manufacturer's recommendation. Brieﬂy,
cells were lysed using a buffer consisting of: 50mMHepes (pH 7.5), 5mMEDTA,150mM
NaCl and 1% Triton X-100, protease inhibitor cocktail and 10 mM N-ethylmaleimide
(NEM). Lysates were incubated with the afﬁnity beads (GST-fusion protein containing
the ubiquitin-associated domain of Rad23 conjugated to glutathione agarose) at 4 °C for
4 h with constant mixing. Beads were washed 3 times with ice-cold wash buffer (lysis
buffer without NEM and protease inhibitors), re-suspended in loading buffer containing
250 mM Tris–HCl, pH 6.8, 4% SDS, 10% β-mercaptoethanol, 20% glycerol, and bromo-
phenol blue. Proteins were resolved on a 10% SDS-PAGE. The level of ubiquitinated
proteins was then assayed by western blot with a rabbit polyclonal anti-ubiquitin
antibody (Sigma).
2.5. Analysis of ER protein ubiquitination
To determine changes in the rate of ubiquitination of ER associated proteins in wt
and crt−/− cells we used both an endogenous protein connexin 43 (Cx43) and an
Table 1
Primer list used for PCR and quantitative RT-PCR in the current study
Gene Primer sequence
CRTstartF 5′ ACTTAAGCTTGGTACCGAGCTC 3′
CRTW244AR 5′ CGGCTCCGCCTCTCCGTCCATTTC 3′
CRTW244AF 5′ GGAGAGGCGGAGCCGCCGGTGATT 3′
CRTendR 5′ GGCCCTCTAGACTACAGCTCG 3′
Calnexin-F 5′ CGCGGATCCATGGAAGGGAAGTGGTTAC 3′
Calnexin-R 5′ GAGATGGAGGAGTGCTGGC 3′
EDEM-F 5′ ATAGCGGCCGCATGCAATGGCGAGCGCTTG 3′
EDEM-R 5′ GAAGACCAACCAGAGCACCG 3′
EDEM2-F 5′ CTACGATGAGCTGAGACCTC 3′
EDEM2-R 5′ CCTGAAGAACCTCCACTACT 3′
EDEM3-F 5′ CAGCTGATGAGCTCATGCCT 3′
EDEM3-R 5′ CAAGGCGTCATCCACATCG 3′
Hrd1-F 5′ ATGTTCCGCACCGCAGTG 3′
Hrd1-R 5′ CATAGTAGGCATGAGCCACC 3′
PSMA1/α6/C2-F 5′ CTGTTTGGAGCCCTCAGG 3′
PSMA1/α6/C2-R 5′ TGTGGTCAGGTCCTGCTC 3′
PSMA5/α5/zeta-F 5′ TCGGTCCGAGTACGACAG 3′
PSMA5/α5/zeta-R 5′ GGTCCCAGATGGGTCCAT 3′
PSMB3/β3/C10-F 5′ CGTCATGGCCATGAAGGGA 3′
PSMB3/β3/C10-R 5′ CGTTCAGCATGGCCTGAG 3′
PSMC3/Rpt5/S6a-F 5′ ACGCCCGAGAGTCCAGTGA 3′
PSMC3/Rpt5/S6a-R 5′ GGGCTGGATACCCAAGTT 3′
PSMC4/Rpt3/S6b-F 5′ GACCTGGAGGACCTGTAC 3′
PSMC4/Rpt3/S6b-R 5′ GGGAGGATCGATGCCAAT 3′
PSMD3/Rpn3/S3-F 5′ ATGAAGCAGGAGGGCTCG 3′
PSMD3/Rpn3/S3-R 5′ CGAGGACGAAACTGCAGGT 3′
PSMD4/Rpn10/S5a-F 5′ CTGCAGGCCCAGCAGGAT 3′
PSMD4/Rpn10/S5a-R 5′ GGCACCAAGACCCAGCAT 3′
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variant-null Hong Kong, a well established substrate for ERAD). A plasmid containing
the A1AT NHK was transiently transfected into both cell types followed by MG132
treatment and ubiquitin pull down assay as described above. Cell lysates were then
resolved on a 10% SDS acrylamide gel and western blot was carried out using rabbit
polyclonal anti-α1-antitrypsin antibody (Dako).
To examine Cx43 ubiquitination, cells were scraped in ice-cold PBS followed by
centrifugation for 30 s at 9000 rpm, 4 °C. Pellets were resuspended in hypotonic buffer
containing 4 mM Hepes, pH7.9, 4 mM NaF, 0.2 mM Na pyrophosphate, 0.2 mM Na
orthovanadate, 0.05 mM Na molybdate, 8 mM β-glycerophosphate, 0.2 mM EDTA,
0.2 mM EGTA, 2 mM DTT, 0.05% NP-40. Cell debris were removed by centrifugation for
30 s at 13,000 rpm and the supernatants were collected for ubiquitin pull down assay as
previously described. To remove the ubiquitin moiety from the enriched ubiquitinated
proteins, the samples were treated with 0.5 μg isopeptidase T (ubiquitin C-terminal
hydroxylase, Calbiochem) in a buffer containing 25mMHepes, pH 7.5 and 10mMDTTat
25 °C. The ubiquitin removal was necessary to unmask the Cx43 antigen. Immunoblot-
ting analysis was carried out using a rabbit polyclonal anti-Cx43 antibody.
2.6. Western blot
Cell lysates containing 30 μg protein (or pull down ubiquitinated proteins) were
separated on a 10% SDS-polyacrylamide gel and blotted to nitrocellulose membrane.
After blocking with 5% milk powder in PBS, the primary antibody was added to the
nitrocellulose membrane and incubated for 3 h. Cytoskeletal actinwas used as a loading
control for each blot. HRP-conjugated secondary antibodies (Jackson Laboratories) were
used followed by enhanced chemiluminescence solution (Santa Cruz Biotechnology).
Fluor-S Max (BioRad) was used to obtain the western blot images. Rabbit polyclonal
anti-ubiquitin antibody was purchased from Sigma (St. Louis). Rabbit polyclonal anti-
bodies to 20S proteasome α/β subunits and 19S regulatory Rpt3 subunit were obtained
from BIOMOL Int. p44S10 subunit was detected by goat polyclonal antibody (Santa Cruz
Biotechnology). Calreticulin and calsequestrin expression was detected by using goat
anti-calreticulin (polyclonal antibody raised against puriﬁed full length rabbit calreti-
culin) and rabbit anti-calsequestrin (polyclonal antibody raised against puriﬁed full
length canine calsequestrin) antibodies. For analysis of expression of myc-tagged exo-
genous proteins (BiP, Calnexin), Western blot was carried out using a rabbit polyclonal
antibody to c-myc (Santa Cruz Biotechnology).
2.7. Quantitative analysis of proteasome activity
Cells were lysed using a buffer containing (ﬁnal concentration): 25mMHepes (pH 7.5),
2.5 mM EDTA, 70 mM NaCl and 0.5% Triton X-100 (modiﬁed from the manufactures
protocol). The proteasome activity in the cell lysate was assayed using a 20S proteasome
assaykit (Calbiochem). Brieﬂy,100–200μgproteinwas incubatedwith the10μMﬂuorogenic
peptide Suc-Leu-Leu-Val-Tyr-AMC, (proteasome substrate III) in a 96-wellmicrotiter plate at37 °C. Proteasomeactivitywasmeasured bymonitoring the release of freeAMC (7-amido-4-
methylcoumarin) using a Spectra Max Gemini ﬂuorimeter and Soft Max Pro 4.0 software
(MolecularDevice). The kinetics of AMC releasewasmeasuredbymonitoring the increase in
ﬂuorescence in 2min intervals for 1 h (excitationmax. 380 nmand emissionmax. 460 nm).
In order to test for substrate speciﬁcity, a group of cellswereﬁrst treatedwith 50 µMMG132
(proteasome inhibitor) for 4 h and then proteasome activity was assayed.
2.8. Substrate overlay assay
To examine changes in the 26S proteasome, a substrate overlayassaywas carried out
as described by Hoffman and Rechsteiner [22]. Brieﬂy, cell lysates from wt and crt−/−
MEF were resolved on non-denaturing gels (4.5% acrylamide gel, 2.3% sucrose, 90 mM
Tris, 80 mM borate, 0.08 mM EDTA) in TBE at 50 V for 16–20 h. The separated proteins
were analyzed for in vitro proteasome activity by incubating the gels with 200 μM Suc-
LLVY-AMC, 2 mM ATP for 30 min at 37 °C. The ﬂuorescent images from each gel were
acquired with a Fluor-S Max (BioRad). 1.5 µg of commercially puriﬁed 20S proteasome
(Calbiochem) was used as a reference.
2.9. Real Time RT-PCR
Total RNA was extracted using a Qiagen RNAeasy Kit (Qiagen). cDNA synthesis and
PCR ampliﬁcation were carried out using iScript One-Step RT-PCR Kit with SYBR Green
(Bio-Rad) and a Bio-Rad iCycler Thermal Cycler. Table 1 shows the list of primers used
for quantitative RT-PCR. All the data were analyzed by iCycler 3.11 software. All primers
were purchased from Sigma Genosys. The Ct (threshold cycle or crossing point) is
deﬁned as the number of cycles required for the ﬂuorescence signal to exceed the
detection threshold. mRNA expression of each speciﬁc gene was normalized to ex-
pression of the GAPDH housekeeping gene, the transcription level of which was not
inﬂuenced under these experimental conditions. Expression of each gene relative to
GADPH was calculated as the difference between the threshold values of the two genes
(ΔCt). The ΔΔCt value describes the difference between the average ΔCt value of crt−/−
cells and the average ΔCt value of wt cells. The values are mean±SE of three separate
experiments.
2.10. Cytotoxicity assay
Equal numbers of wt and crt−/− cells were plated in 10 cm2 plates and allowed to
adhere overnight. Next day, the media was replaced with media containing 10 μM
lactacystin and cells were incubated for 16 h at 37 °C. Cells were washed with PBS and
the percent live cells were calculated using a Live/Dead assay kit (Molecular Probes)
following the manufacturer's protocols. Brieﬂy, cells were mixed with equal volume of
Live/Dead working solution containing Calcein AM (4 µM) and Ethidium homodimer-1
(8 µM EthD-1) for 30 min at room temperature. Calcein AM is a cell permeable dye
which will be retained in the live cells producing a green ﬂuorescence. EthD-1 is taken
up only by the damaged cells and its binding to DNA emits red ﬂuorescent signal. The
number of live cells was calculated from the ﬂuorescent readings at 538 nm of each
sample by Spectra Max Gemini plate reader and plotted as a percentage relative to
control samples (no treatment). For ﬂuorescent microscopy, cells were cultured on
sterile glass coverslips until 90% cell density was obtained and then treated with 10 μM
lactacystin for 12 h or 70% EtOH for 30 min (killing all the cells, a positive control).
Coverslips were then washed with PBS and incubated with 4 µM EthD-1 for 45 min at
room temperature. Coverslips were mounted to microscope slides and viewed with the
ﬂuorescent microscope using the Texas red ﬁlter.
2.11. Electron microscopy
Cells were ﬁxed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M Na
cacodylate buffer pH 7.2 for 4 h at room temperature. The cells were then processed for
embedding and sectioning as described in [23]. Ultrathin sections were examined using
a Phillips 410 electron microscope and images were obtained on Kodak electron mic-
roscope ﬁlm negatives at a magniﬁcation of 10,000×.
2.12. Quantiﬁcation of data and statistical analysis
Data quantiﬁcation for the ubiquitin pull down experiment was obtained by den-
sitometric quantiﬁcation of the bands using a Quantity One 4.5.0 analytical software
(BioRad). Statistical analysis was performed using Sigma Stat 3.11 and Sigma Plot 9.0.
Statistical differences were assessed using Student's t-test (independent).
3. Results
3.1. Increased proteasome activity in calreticulin deﬁcient cells
Fig. 1A shows the ER ultra-structure of wt and crt−/− cells using
electron microscopy and reveal no signiﬁcant changes in ER upon
induction of UPR in crt−/− cells. To determine the effect of loss
of calreticulin function on the ubiquitin–proteasome pathway, we
ﬁrst examined changes in total cellular ubiquitination. Total cellular
Fig. 2. (A) Increased susceptibility of crt−/− cells to cell death following treatment with
proteasome inhibitor lactacystin. Cells were incubated in the presence or absence of
lactacystin (10 μM) for 16 h followed by analysis with a Live/Dead assay kit. The values
are mean±SE of three separate experiments. ⁎ pb0.05 signiﬁcantly different as com-
pared to wt cells. (B) Effect of lactacystin (LC) on cell viability. Wt and crt−/− cells were
treated with 10 μM lactacystin for 12 h, 70% EtOH (positive control) and their viability
was assessed by labeling the cells with 4 μM Etd-1. The Etd-1 positive dead cells were
visualized using a ﬂuorescence microscope (Zeiss AxioScop 2).
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beads. As shown in Fig.1B, therewas no signiﬁcant difference between
the ubiquitination proﬁles of non-treated crt−/− and wt cells. To
establish whether there were any changes in the rate of proteasome
activity due to loss of calreticulin function, cells were treated with the
proteasome inhibitor (MG132) for 4 h. This treatment resulted in a
signiﬁcant increase in the level of ubiquitinated proteins in thewt and
crt−/− cells (Fig. 1B). However, the percentage increase in the ubi-
quitinated proteins in the MG132 treated crt−/− cells were signiﬁ-
cantly higher than in the MG132 treated wt cells (Fig. 1B bar graph).
This observation suggests that there is a higher rate of ubiquitination
in crt−/− as compared to wt cells and the increased proteasome acti-
vity results in faster degradation of ubiquitinated proteins, as seen by
the equivalent basal levels of ubiquitinated proteins in the untreated
cells (Fig. 1B, bar graph).
To study the changes in ubiquitination of ER associated proteins
in these cells we compared the rates of ubiquitination of Cx43
(endogenous protein) and A1AT NHK (an exogenously expressed
protein). Cx43 folding and initial oligomerization has been shown to
be carried out in the ER [24], whereas A1AT NHK is a well known
glycoprotein-ERAD substrate [9]. Both Cx43 and A1AT NHK are
degraded via the ubiquitin proteasome pathway [25,26]. As shown
in Fig. 1C the degree of Cx43 and A1AT NHK ubiquitination is sig-
niﬁcantly higher in the crt−/− compared to the wt cells. These data
illustrates that loss of calreticulin function increases ubiquitination
and degradation of ER substrates.
Next, we measured proteasome activity in cell lysates prepared
from non-treated and MG132 treated wt and crt−/− cells. Fig. 1D
shows that there is a 35% increase in proteasome activity of crt−/− cells
as compared to wt cells in the untreated condition. Furthermore, pre-
treatment of the cells with MG132, for 4 h before preparation of cell
lysate, resulted in complete inhibition of proteasome activity in both
cell types (Fig. 1D). To distinguish between the activity of the 26S
proteasome and 20S proteasome, we carried out a substrate overlay
assay which differentiates between the two complexes based on their
molecular weight. Fig. 1E shows the location of the 20S proteasome
(puriﬁed protein, Calbiochem) and 26S proteasome (from 100 µg wt
cell lysates) on a non-denaturing acrylamide gel after the substrate
overlay assay. Fig. 1E also shows that the 26S proteasome encom-
passes the major component of the proteasome activity in the cell
lysates since the 20S proteasome activity was not detectable. As
shown in Fig. 1F, the enzymatic activity of the 26S proteasome is
higher in crt−/− cells lysates as compared to the wt cells. Interestingly,
there was no detectable proteasome activity corresponding to the 20S
in the cell lysate preparations from either wt or crt−/− cells (Fig. 1F).
Previous reports have shown that crt−/− cells are more resistant to
both drug and UV induced apoptosis [20,27]. Furthermore, inhibition
of proteasome activity has been shown to induce cell death in many
cell types including tumor cells [28,29]. Therefore, we examined
whether this elevated proteasome activity is a compensatory mecha-
nism essential for crt−/− cell survival. Cell death was measured in wt
and crt−/− cells after exposure to lactacystin (10 µM for 16 h). Fig. 2
shows an increased rate of cell death following treatment with
lactacystin in both cell types. However, crt−/− cells weremore prone to
cell death after this treatment (Fig. 2). Similar data was also observed
following treatment with another proteasome inhibitor MG132 (data
not shown).
3.2. mRNA levels of proteasome subunits in crt−/− cells
The increased proteasome activity in crt−/− cells could be mediated
either by increased expression of proteasome subunits or increased
enzymatic activityof theproteasomecomplexes. To examine the changes
in the proteasome subunit expression, we carried out quantitative real-
time PCR analysis of seven key proteasome subunits [α5, α6, β3 (com-
ponent of the 20S complex), Rpt3, Rpt5 (ATPase's of 19S base complex),Rpn3 and Rpn10 (19S lid and base components required for ubiquitin
recognition)]. Table 2 summarizes the data from three separate expe-
riments for each subunit. Table 2 demonstrates a decrease in themRNA
expression of α5, α6, β3, Rpt3, and Rpn3 subunits crt−/− cells relative
to wt cells. Furthermore, there were no signiﬁcant changes in the
Rpt5 and Rpn10 gene expression (Table 2). These results indicate that
the increased proteasome activity in crt−/− cells is not due to an up-
regulation of proteasome gene expression or increase in the number
of 26S proteasome complexes. Indeed, a recent report on an ovarian
cancer cell line showed that increased activity of the ubiquitin–pro-
teasome pathway, and not increased expression of its components,
augments the sensitivity of these cells to undergo apoptosis upon
treatment with proteasome inhibitors [29]. To determine whether
decreased mRNA corresponded with decreased protein, the protein
levels of several proteasomal subunits were determined in wt and
crt−/− cells by Western blot analysis (Fig. 3). As shown in Fig. 3,
there was no signiﬁcant difference in the amount of Rpt3 (a subunit
of 19S complex) or α/β subunits (20S complex). Whereas, the level of
Fig. 4. (A) Changes in the proteasome activity following induction of ER stress. Chy-
motrypsin like activity of the proteasome were measured by ﬁrst treating the cells with
0.1 μM thapsigargin (TG) 1h, 1 μg/ml tunicamycin (TN) 3h, or 7 μM brefeldin A (BF) 3 h,
followed by preparation of cell lysate and proteasome assay (as described in Materials
and methods). The values are mean±SE of three separate experiments. ⁎ pb0.05
Table 2
Real time RT-PCR expression analysis of proteasomal subunits
Gene/Subunit Relative mRNA expression levels
Ratio crt−/−/wt
PSMA1/α6/C2 0.77±0.10
PSMA5/α5/zeta 0.73±0.06
PSMB3/β3/C10 0.52±0.12
PSMC3/Rpt5/S6a 0.92±0.15
PSMC4/Rpt3/S6b 0.73±0.06
PSMD3/Rpn3/S3 0.55±0.09
PSMD4/Rpn10/S5a 0.92±0.16
The values are given as normalized target gene expression of crt−/− versuswt cells (2−ΔΔct,
the ΔΔCt value is the difference between the average ΔCt value (threshold value of each
gene toGAPDH)of crt−/− cells and the averageΔCt value ofwt cells). The values aremean±
SE of three separate experiments.
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was slightly lower in crt−/− as compared to wt cells. These data con-
ﬁrm that proteasome subunit expression is not signiﬁcantly altered in
crt−/− cells.
3.3. Mechanism of regulation of proteasome activity in wt and crt−/− cells
Next, we examined the effect of ER stress on proteasome activity.
As shown in Fig. 4A, induction of ER stress following 3h treatment
with thapsigargin (depleting intracellular Ca2+) had no effect on pro-
teasome activity in wt or crt−/− cells. Furthermore, tunicamycin (an
inhibitor of N-linked glycosylation) induced ER stress caused less than
10% increase in the proteasome activity in wt cells, whereas, this
treatment signiﬁcantly increased the proteasome activity in crt−/−
cells (Fig. 4A). Similar changes in proteasomal activity were observed
when cells were treated with brefeldin A (which disrupts Golgi struc-
ture and trafﬁcking) (Fig. 4A). Previous report showed an increase in
calnexin expression in crt−/− cells [17]. Thus we examined the effect of
overexpression of calnexin and BiP on proteasome function. As shown
in Fig. 4B, overexpression of eithermyc tagged calnexin or BiP induced
only a slight increase (less than 10%) in proteasome function of the wt
cells despite the high level of expression of both of these proteins.signiﬁcantly different as compared to untreated cells. † pb0.05 signiﬁcantly different as
compared to corresponding wt cells. (B) Overexpression of ER chaperones, BiP or
calnexin (CNX), in wt cells did not affect proteasome activity. Wt cells were transiently
transfected with myc-BiP or myc-CNX after 48 h cells were lysed and proteasome
activity was assayed. Western blot with anti-myc and actin shows the level of expres-
sion ofmyc-BiP,myc-CNX and actin in the same cell lysate used to measure proteasome
activity. Bar graphs are mean±SE of three separate experiments. ⁎ pb0.05 signiﬁcantly
different as compared to non-transfected cells.
Fig. 3. Analysis of expression of proteasomal subunits in wt and crt−/− cells. Western
blot were carried out using cell lysates from wt and crt−/− cells and antibodies speciﬁc
to α/β subunits, Rpt3 p44S10 and CRT. The same blots were stripped and probed with
antibody to actin as a loading control. α/β subunits belong to the 20S complex (core of
proteasome), while Rpt3 and p44S10 are subunits of 19S component (the lid part of the
26S proteasome).To further establish the mechanism of regulation of proteasome
activity in crt−/− cells, we independently tested the two primary
functions of calreticulin. Calreticulin functions as a regulator of Ca2+
homeostasis and an ER chaperone [14]. Recently, Ca2+ has been shown
to activate 20S proteasome in vitro [30]. Moreover, proteasome activity
could be signiﬁcantly elevated upon treatment of L6 muscle cells with
the Ca2+ ionophore A23187 [31]. Therefore, we testedwhether the Ca2+
regulatory function of calreticulin can modulate proteasome activity.
In crt−/− MEF cells, the resting free cytosolic Ca2+ concentration is
signiﬁcantly higher as compared towt cells [18]. These cells also have a
lower ER capacity for Ca2+ storage, although the free ER Ca2+ concen-
tration is not changed [18]. Therefore, we examined the effect of in-
creasing intracellular Ca2+ on proteasome activity. Fig. 5A shows that
treatingwt and crt−/− cellswith the Ca2+ ionophore ionomycin induced
a signiﬁcant increase in the proteasome activity ofwt cells but did not
change proteasome activity of the crt−/− cells. This differential effect of
ionomycin could be due to the fact that crt−/− cells has a signiﬁcantly
higher basal level of cytosolic Ca2+ (~50% higher) which results in
higher basal proteasome activity in these cells. Therefore, increasing
Fig. 5. Effect of changes in intracellular Ca2+ on proteasome activity. (A) Chymotrypsin like activity of the proteasomewas measured upon treatment of cells with 6 μM ionomycin (IC)
or buffer control (N/T) in the presence of 2 mM Ca2+ for 2 h. Values are expressed as percentage of the proteasome activity in the wt cells. The values are mean±SE of three separate
experiments. ⁎ pb0.05 signiﬁcantly different as compared to non-treated cells. (B) Effect of intracellular Ca2+ on the activity of 26S proteasome in wt cells. To chelate all intracellular
Ca2+, cells were incubated with 50 μM BAPTA-AM in the presence of 0.02% pluoronic acid and 250 μM sulﬁnpyrazone for 30 min. To increase cytosolic Ca2+ cells were treated with
2 μM ionomycin in the presence of 2mMCa2+ for 3 h. Cell lysate isolated after each treatmentwere resolved on a nondenaturing gel followed by overlay assay (using Suc-LLVY-AMC as
a substrate). (C) Chymotrypsin like activity of the proteasome were measured in crt−/− cells transiently transfected with a plasmid containing HA-calreticulin (CRT), calsequestrin
(CSQ) or the empty vector (V). Lower panel is a western blot with antibody to calreticulin and calsequestrin showing the expression of the exogenous protein in the crt−/− cells. The
bar graph values are mean±SE of four separate experiments expressed as percentage ofwt cells. ⁎ pb0.05 signiﬁcantly different as compared to vector transfected cells. In Fig. 5B the
loading wells are cut off.
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elicit any additional activation of the proteasome. Furthermore, using a
substrate overlay assay we showed that chelation of intracellular Ca2+
by BAPTA-AM abolishes 26S proteasome activity (Fig. 5B ﬁrst lane),
whereas ionomycin signiﬁcantly increases this activity (Fig. 5B last
lane). Expression of calreticulin in crt−/− cells has been shown to de-
crease the basal cytosolic Ca2+ concentration close to that of wt cells
[18]. Thuswe examinedwhether reintroduction of calreticulin in crt−/−
cells has any effect on the proteasome activity. As shown in Fig. 5C,
calreticulin transfected crt−/− cells showed signiﬁcantly lower protea-
some activity as compared to the vector transfected crt−/− cells (110±2%
for CRT-crt−/− vs. 134±3 for vector+crt−/−). The proteasome activity in
the CRT+crt−/− cells (110%) was still slightly higher than that of wt
(100%) likely due to the fact that the expression of calreticulin in CRT+
crt−/− cells was less than that of the wt cells (Fig. 5C). In addition, to
determine the role of ERCa2+ buffering capacity onproteasome function
we transfected crt−/− cells with calsequestrin (Fig. 5C). Calsequestrin is
a Ca2+ binding protein, localized to the muscle sarcoplasmic reticulum,
that is similar to calreticulin in Ca2+ regulation but unlike calreticulin itdoes not have a chaperone function [32]. Calsequestrin is not expressed
endogenously in MEF cells. Interestingly, calsequestrin was able to sig-
niﬁcantly decrease the proteasome activity (82±6% for CSQ+crt−/−) in
crt−/− cells (Fig. 5C).
To differentiate between the Ca2+ buffering capacity (located in the
C-domain of calreticulin) and the lectin-like chaperone (P-domain of
calreticulin) function of the re-introduced calreticulin on proteasome
function, we explored the effect of different calreticulin domains and
their ability to modulate the activity of the ubiquitin–proteasome
pathway. We used calreticulin deletion mutants generated by
removing the C-domain (CRTNP) or theN-domain (CRTPC) of calreticulin.
Calreticulin deletion mutants (CRTNP and CRTPC) or full length
calreticulin were introduced into crt−/− cells and proteasome activity
wasmeasured (Fig. 6A, B). As shown in Fig. 6B, both deletionmutants of
calreticulin, CRTNP and CRTPC were able to reduce the proteasome
activity to that observed in the CRT+crt−/− levels. The vector alone had
no effect on proteasome activity (Fig. 6B). All of the three expressed
proteins (calreticulin, CRTNP and CRTPC) contain an intact P-domain of
calreticulin, which suggest a role for this domain in the observed
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P-domain containsboth thehigh afﬁnityCa2+ binding site and the lectin-
like chaperone site of calreticulin [14]. Therefore, we examined the role
of this domain on the activity of proteasome by site directed mutations
at Trp244 (W244A). Trp244 mutation has been shown to disrupt the P-
domain structure and thus affect the carbohydrate binding pocket in
calreticulin [33]. Furthermore, this mutation has been shown to
decrease binding of another ER chaperone, Erp57, to calreticulin [33].
Fig. 6A lower panel shows that transfection of crt−/− with CRTW244A or
CRTNP-W244A resulted in the expression of protein bands at the
expected size. However, several attempts to express the CRTPC-W244A
in the crt−/− cells failed to produce anyprotein and could be attributed to
decreased stability of this mutant protein. As shown in Fig. 6B,
expression of CRTNP-W244A in crt−/− did not alter the proteasome activity
as compared to the empty vector transfected crt−/− cells. However,
introduction of CRTW244A resulted in a proteasome activity which was
signiﬁcantly less than the empty vector transfected crt−/− cells (Fig. 6B)
but higher than the calreticulin transfected cells (not statistically
signiﬁcant). This suggests that both the P and C-domains of calreticulin
are important for its modulation of the proteasome activity.
3.4. Effect of calnexin depletion on proteasome activity
Calreticulin and calnexin are homologous ER chaperones which
play an important role in the quality control of N-linked glycans foldingFig. 6. Changes in proteasome activity upon reintroduction of calreticulin or its deletion mu
crt−/− cells and crt−/− cells transiently transfected with expression vectors encoding calret
CRTNP-W244A and CRTPC-W244A). m represents the location of the calreticulin deletion mut
CRTW244A and CRTNP-W244A. The levels of activity were compared relative to non-transfecte
signiﬁcantly different as compared to the vector-transfected crt−/− cells. (C) Effect of calnex
with siRNA to calnexin or a control non-targeting siRNA (siRNA-A). 24 h after transfection,
showing the level of cellular calnexin after transfection with calnexin-siRNA or control si
(D) Effect of kifunensine on proteasome activity in wt and crt−/− cells. Kifunensine was add
proteasome activity was measured. The values are mean±SE of three separate experiment[7]. In crt−/− cells, calnexin gene expression is increased (Table 3)
leading to increased calnexin protein levels, see Fig. 6C, lower panel
and [17]. The increased calnexin expression in these cells could be a
mechanism of UPR pathway in order to compensate for the absence of
calreticulin. Therefore, we examined the effect of down regulation of
calnexin on proteasome activity in these cells. Transfection of wt and
crt−/− cells with a siRNA speciﬁc for calnexin signiﬁcantly decreased
(60%) calnexin protein level in both cell types as compared to non-
targeting control siRNA-A (Fig. 6C lower panel). Interestingly, this
decrease in calnexin protein in the wt cells did not affect proteasome
activity (Fig. 6C bar graph). In contrast, down regulation of calnexin
protein in the crt−/− cells signiﬁcantly increased the proteasome ac-
tivity (Fig. 6C bar graph). These data suggests that in crt−/− cells up-
regulation of calnexin is an essential compensatory mechanism in
order to process the increased amount of misfolded proteins in the ER.
3.5. Inhibition of ER α1,2-mannosidase I indirectly decreases proteasome
activity
Translocation of misfolded proteins across the ER membrane re-
gulates the availability of substrates for ERAD and therefore could be a
limiting factor in this process. To enter ERAD, the misfolded glyco-
proteins must dissociate from calnexin a process which requires man-
nose trimming by α1,2-mannosidase I [8]. Kifunensine is a speciﬁc
inhibitor of α1,2-mannose residues trimming from N-glycans and wastants in crt−/− cells. (A) Western blot analysis with anti-calreticulin antibody of the wt,
iculin (CRT-crt−/−) or calreticulin deletion and point mutants (CRTNP, CRTPC, CRTW244A,
ants. (B) Proteasome activity in the crt−/−, vector transfected (V), CRT, CRTNP, CRTPC,
d wt and crt−/− cells. Bar graphs are mean±SE of 3–6 separate experiments. ⁎ pb0.05
in (CNX) depletion on proteasome activity in wt and crt−/− cells. Cells were transfected
cells were lysed and proteasome activity was measured. Lower panel is a Western blot
RNA. ⁎ pb0.05 signiﬁcantly different as compared to siRNA-A transfected crt−/− cells.
ed to the cell cultures at a ﬁnal concentration of 5 μg/ml. 4 h later cells were lysed and
s. ⁎ pb0.05 signiﬁcantly different as compared to non-treated cells.
Fig. 6 (continued ).
Table 3
Real time RT-PCR analysis of proteins involved in ERAD proof-reading and protein
translocation
Gene Relative mRNA expression levels
Ratio crt−/−/wt
Calnexin 2.14±0.41⁎
Hrd1/Syvn1 1.35±0.10⁎
EDEM1 1.64±0.16⁎
EDEM2 1.05±0.13
EDEM3 0.80±0.11
The values are given as normalized target gene expression of crt−/− versuswt cells (2−ΔΔct,
see Table 2). The values aremean±SEof three separate experiments. ⁎ pb0.05 signiﬁcantly
different as compared to wt cells.
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that kifunensine signiﬁcantly reduces proteasome activity in both
wt and crt−/− cells. These data are supportive of a direct functional
link between two separate stages of ERAD pathway, translocation and
degradation.
3.6. Changes in mRNA levels of calnexin, EDEM and Hrd1 in crt−/− cells
Accumulation of misfolded proteins in the lumen of ER in crt−/−
cells and their efﬁcient removal requires enhanced recognition of mis-
folded proteins and their faster translocation from ER to the cytoplasm
which could be achieved via increased expression of the proteins in-
volved in these process namely calnexin, EDEM (three isoforms) and
Hrd1(ubiquitin ligase). Real-time PCRusingmRNA isolated fromwt and
crt−/− cells revealed a signiﬁcant increase in the mRNA levels of cal-
nexin, EDEM1 and Hrd1 (Table 3). No changes were observed in the
levels of EDEM2 and EDEM3. Calnexin and EDEM1 are lectins required
for recognition and dislocation of terminally misfolded glycoproteins,while Hrd1 is a multi-spanning RING-ﬁnger quality control ubiquitin
ligase, assisting in retrograde translocation of misfolded proteins.
4. Discussion
Calreticulin, in associationwith calnexin, plays an important role in
the proper folding of nascent glycoproteins. Thus elimination of this
protein could lead to the accumulation of misfolded glycoproteins in
the ER thereby clogging the ER protein folding machinery. As a com-
pensatory mechanism UPR is induced in crt−/− cells, resulting in a
signiﬁcant increase in the expression of other ER chaperones such as
calnexin and BiP [17]. Interestingly, crt−/− cells do not show any dif-
ference in the ER ultra-structure (Fig.1A) or any changes in the total ER
glycoproteins. In this study, we provide the ﬁrst evidence that crt−/−
cells are able to survive via the activation of the ubiquitin–proteasome
pathway. Indeed, proteasome inhibition results in a signiﬁcantly higher
accumulation of ubiquitinated proteins in crt−/− cells (Fig. 1B) and
increased cell death (Fig. 2A, B). Furthermore, we showed that the
ubiquitination of two ER substrates, Cx43 and A1AT NHK, are signi-
ﬁcantly increased in the crt−/− cells (Fig. 1C). This increase in protein
ubiquitination anddegradation in crt−/− cells could be due to activation
of ERADwhich is a compensatory mechanism in order to retain the ER
protein folding capacity.
ERAD is a multi-step process important for efﬁcient removal of
unfolded andmisfolded proteins from the lumen of ER. The ubiquitin–
proteasome activity represents a major component of this process [4].
ER stress has been shown to trigger upregulation of several proteins
known to be a functional part of ERAD, including calnexin/calreticulin
[17], EDEM [8,11] and Hrd1 [35]. Interestingly, in wt cells where the
function of all components of ERAD is conserved, induction of ER
stress (by thapsigargin, tunicamycin, or breﬂedin A) (Fig. 4A) or over-
expression of other ER chaperones (BiP or calnexin) (Fig. 4B) induces
only slight changes in the activity of the proteasome. In contrast, upon
deletion of calreticulin the elevated activity of proteasome (Fig. 1D) is
further increased upon treatment with pharmacological agents that
induce ER stress (Fig. 4A). This increase could be attributed to the fact
that crt−/− cells are already under ER stress [17] and further ER stress
could heighten ERAD. In addition, accumulation of unfolded proteins
in crt−/− cells was shown to induce Ire1α and PERK kinases [17] thus
activating signalling cascades and transcriptional upregulation of lu-
minal chaperones such as BiP, Grp94 and calnexin which are involved
in ER stress. The combined induction of ER chaperones, proteins in-
volved in ERAD and ubiquitin–proteasome activity illustrates the ex-
istence of a complex network to overcome the stress induced upon
loss of an ER chaperone function. Indeed, reduction of calnexin ex-
pression (by 60%) in the crt−/− cells by siRNA induced a 100% increase
in the proteasome activity (Fig. 6C) whereas a similar decrease in
calnexin expression in wt cells did not signiﬁcantly affect proteasome
activity. Elevation of proteasome activity in crt−/− cells upon reduction
of calnexin function (Fig. 6C) could be due to overloading of the ER
with misfolded proteins. Consequently, the increased ER stress would
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degradation. Interestingly, inhibition of α1,2-mannose trimming from
improperly folded N-glycans by kifunensine, and therefore indirectly
altering retrograde transport of ER substrates, negatively affected
proteasome activity (Fig. 6D). These data supports the idea that the
observed increase in calnexin expression (Table 3 and Fig. 6C lower
panel) and other proteins involved in ERAD compensates for the ab-
sence of calreticulin and facilitates the removal of misfolded proteins
from the ER. Our work revealed a novel cytoprotective mechanism in
calreticulin deﬁcient cells as a counterbalance for the diminished
folding potential in order to facilitate the removal ofmisfoldedproteins
from the ER. As a result ER structure is maintained and the whole
system reaches an adaptive equilibrium in crt−/− cells.
Mutation analysis of calreticulin protein had demonstrated that
Trp244 located in the hairpin tip of calreticulin P-domain is important
for binding of calreticulin to other ER resident chaperones (e.g. ERp57)
[33]. This mutationwas shown to affect the structure of the P-domain
of calreticulin by possibly affecting the stability of this region and
impairing carbohydrate binding to calreticulin [33]. Loss of ERp57
binding in the CRTW244A and CRTNP-W244A mutants therefore could be
crucial for luminal organization of chaperone function and folding
network inside the cells which could elucidate the failure of these
mutants to reverse the increase in the proteasome activity (Fig. 6B).
Thus, Fig. 6 also illustrate that the organization and composition of ER
folding network could affect the ERAD process. Interestingly, protein–
protein interactions between various components of this network are
dependent on ER luminal Ca2+ levels and could be affected by the
buffering capacity of ER. Our studies also suggested that loss of cal-
reticulin's chaperone function alone in crt−/− cells may not be the only
mechanism for proteasomal activation. In addition to its chaperone
function, calreticulin also plays an important role in the regulation of
Ca2+ homeostasis [14]. Two recent reports have demonstrated a role
for free Ca2+ concentration on proteasome activity both in vitro and
in vivo [30,31]. Therefore, it is possible that enzymatic activation
of proteasome in crt−/− cells is facilitated by increased free cytosolic
Ca2+. In this study, we showed that re-introduction of full length
calreticulin, CRTPC (N-domain deletion) (Fig. 6B) or a Ca2+ binding
homologue, calsequestrin (Fig. 5C) in crt−/− cells resulted in a signi-
ﬁcant decrease in the proteasome activity. Calsequestrin is a Ca2+
buffering protein associated with sarcoplasmic reticulum of skeletal
and cardiac muscle [32]. Calsequestrin has a moderate afﬁnity (Kd~
4–40 µM) and high capacity (40–50 mol Ca2+ mol−1 calsequestrin) for
Ca2+ but is not involved in protein chaperoning and maturation [32].
Furthermore, using a substrate overlay assay we showed that quench-
ing intracellular Ca2+ by BAPTA-AM abolishes 26S proteasome activity,
while increasing intracellular Ca2+ by ionomycin increases this activity
in thewt cells (Fig. 5B). Reshetnyak et al. [30] have recently illustrated
that divalent cations, Ca2+ and Mg2+, alters the conformation of the
catalytic complex of proteasome (20S proteasome) thus enhancing the
enzymatic activity of this protein in vitro. Thus changes in cytosolic
Ca2+ concentration could result in transformation of intrinsic protea-
some activity in order for the cell to adapt to the altered intracellular
milieu upon loss of calreticulin function.
Our data collectively elucidates that the function of calreticulin in
the regulation of intracellular Ca2+ homeostasis and cytosolic free Ca2+
and to a lesser extent its chaperone function through its P-domain are
important for activation of proteasome.
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